Clinical Trials Browser

Phase 3 × Unilateral Breast Neoplasms × 30 days × Clear all

NCT06760637 2026-03-02

FourLight-3

Phase 3 Recruiting

Unilateral Breast Neoplasms, Breast Neoplasms, Recurrence